AI Summary
This article focuses on using novel PROTAC probes to target KDM3 for degradation in order to eliminate colorectal cancer stem cells through the inhibition of Wnt/β-catenin signaling. The study demonstrates the efficacy of the synthesized PROTACs in selectively degrading KDM3A and KDM3B, leading to the suppression of oncogenic Wnt signaling and tumor growth. The findings suggest that PROTACs could be a valuable tool for developing small molecules to target KDM3 and eliminate colorectal CSCs.
It has been demonstrated that the KDM3 family of histone demethylases (KDM3A and KDM3B) epigenetically control the functional properties of colorectal cancer stem cells (CSCs) through Wnt/β-catenin signaling. Meanwhile, a broad-spectrum histone demethylase inhibitor, IOX1, suppresses Wnt-induced colorectal tumorigenesis predominantly through inhibiting the enzymatic activity of KDM3. In this work, several cereblon (CRBN)-recruiting PROTACs with various linker lengths were designed and synthesized using IOX1 as a warhead to target KDM3 proteins for degradation. Two of the synthesized PROTACs demonstrated favorable degradation profile and selectivity towards KDM3A and KDM3B. Compound 4 demonstrated favorable in vitro metabolic profile in liver enzymes as well as no hERG-associated cardiotoxicity. Compound 4 also showed dramatic ability in suppressing oncogenic Wnt signaling to eliminate colorectal CSCs and inhibit tumor growth, with around 10- to 35-fold increased potency over IOX1. In summary, this study suggests that PROTACs provide a unique molecular tool for the development of novel small molecules from the IOX1 skeleton for selective degradation of KDM3 to eliminate colorectal CSCs via suppressing oncogenic Wnt signaling.
This article is Open Access
Please wait while we load your content… Something went wrong. Try again?